3-(CHLOROMETHYL)-5-METHOXYPYRIDINE HYDROCHLORIDE, 95%, 1g

4-Iodo-3,5-dimethylpyrazole>98.0%(GC)5g

4-Dimethylaminobenzylidenerhodanine>98.0%(T)25g

(4S,4'S)-2,2'-(Propane-2,2-diyl)bis(4-phenyl-4,5-dihydrooxazole), 95.0%, 5g

(R)-6-METHYLMORPHOLIN-3-ONE, 95%, 5g

2,2,2-Trichloro-1-(4-nitro-1h-pyrrol-2-yl)ethan-1-one, 95+%, 250mg

3-(3-Bromophenoxy)pyrrolidine hydrochloride, 97%, 100mg

N-(1,4-dioxo-3-(pyrazin-2-ylmethylamino)-1,4-dihydronaphthalen-2-yl)-N-(2-methoxyethyl)acetamide, 98%, 100mg

1-(2-Chloro-4-fluorophenyl)cyclopropane-1-carboxylic acid, 98%, 250mg

N-(4-BROMOPHENYL)-4-METHYLBENZENESULFONAMIDE, 95.0%, 100mg

(E)-2-Methyl-3-(1-phenyl-ethylamino)-but-2-enoic acid ethyl ester, 95.0%, 1g

Recipiente de reacción con brida plana, cilíndrico, graduado, con camisa de templado y vacío y válvula de drenaje, DN 100, 4000 ml, 250 mm, 1 pieza

Glutaraldehído 50 %, 500 ml